Product Introduction:
Glycomet Trio SR is a fixed-dose combination tablet containing:
-
Vildagliptin 0.2 mg (a DPP-4 inhibitor that increases insulin release)
-
Metformin 500 mg (a biguanide that decreases glucose production and improves insulin sensitivity)
-
Voglibose 1 mg (an alpha-glucosidase inhibitor that slows carbohydrate absorption)
This combination works synergistically to control blood glucose levels in patients with type 2 diabetes.
Uses:
-
Management of type 2 diabetes mellitus
-
Control of fasting and postprandial blood glucose levels
Benefits:
-
Improves insulin secretion
-
Reduces hepatic glucose production
-
Slows carbohydrate absorption from the intestines
-
Helps maintain better blood sugar control
Composition:
Each sustained-release tablet contains:
-
Vildagliptin 0.2 mg
-
Metformin Hydrochloride 500 mg
-
Voglibose 1 mg
Side Effects:
Possible side effects include:
-
Gastrointestinal discomfort (nausea, diarrhea, abdominal pain)
-
Headache
-
Dizziness
-
Hypoglycemia (low blood sugar) especially when combined with other antidiabetics
-
Allergic reactions (rare)
Safety Advice:
-
Take as prescribed, preferably with meals
-
Monitor blood sugar levels regularly
-
Inform your doctor if you have kidney or liver problems
-
Avoid alcohol consumption during treatment
-
Store in a cool, dry place away from direct sunlight
